| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 3,5000% | ₹502.25 0% | 3,100 | ₹1.35 125% | 4,0000% |
| - | - | 3,200 | ₹2.5 100% | 1,500100% |
| - | - | 3,250 | ₹4.75 79.24% | 5,250-4.54% |
| 1,2500% | ₹285.45 0% | 3,300 | ₹8.1 68.75% | 10,500-27.58% |
| 5000% | ₹253.75 0% | 3,350 | ₹13 67.74% | 14,000-22.22% |
| 3,50075% | ₹152 -21.2% | 3,400 | ₹20.6 67.47% | 49,000-4.85% |
| 2,2500% | ₹163.1 0% | 3,450 | ₹33 83.84% | 8,000-23.80% |
| 34,2506.20% | ₹85 -26.4% | 3,500 | ₹49.45 56.48% | 49,2505.34% |
| 62,5002.04% | ₹61 -27.59% | 3,550 | ₹77.55 58.1% | 18,75010.29% |
| 1,06,25010.67% | ₹37 -38.12% | 3,600 | ₹105.65 42.38% | 28,500-16.78% |
| 36,2509.84% | ₹27 -34.38% | 3,650 | ₹146.65 48.5% | 13,750-5.17% |
| 77,5006.52% | ₹18 -33.7% | 3,700 | ₹118.75 0% | 9,2500% |
| 12,25019.51% | ₹12.35 -28.4% | 3,750 | ₹226.55 29.42% | 6,7500% |
| 34,0000% | ₹7.65 -34.05% | 3,800 | ₹232.8 0% | 2,2500% |
| 14,75055.26% | ₹5.35 -32.7% | 3,850 | - | - |
| 17,500-5.40% | ₹3.9 -27.1% | 3,900 | ₹321.9 0% | 1,5000% |
| 10,0000% | ₹3.95 0% | 3,950 | ₹338.65 0% | 7,5000% |
| 40,250-4.16% | ₹2.15 -27.11% | 4,000 | ₹411 0% | 1,0000% |
| 24,25012.79% | ₹1.5 -31.81% | 4,100 | ₹533.3 0% | 10,7500% |
| 7,7500% | ₹1.25 0% | 4,200 | ₹612.7 0% | 5,7500% |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
